The company hopes the decision will help it compete in the obesity market, a sector that has been in the spotlight this year as GLP-1s skyrocketed in popularity as weight loss drugs
Most other serious stomach issueslike ulcers, pancreatitis, or bleedingdid not increase with these drugs
BMC Neurosci 17(1):37 Barreto-Vianna ARC, Aguila MB, Mandarim-de-Lacerda CA (2017) Beneficial effects of liraglutide (GLP1 analog) in the hippocampal inflammation
Both are taken once daily and have strong clinical evidence supporting their effectiveness for weight management
27 investigated the effects of varying doses of liraglutide, ranging from 1.2 to 3 mg, in comparison to placebo and orlistat, expanding our understanding of the relationship between liraglutide and psychiatric outcomes
What you need to evaluate carefully is the regulatory environment: compounded GLP-1 availability is under ongoing FDA review in 2026